Howard D. Silverman, MD, professor in the Department of Biomedical Informatics at the College of Medicine – Phoenix, is quoted in an explainer on medical specialties, including biomedical informatics, which involves collecting and analyzing patients’ health information and applying those insights to improve health.

The Drug Enforcement Agency received a recommendation to reclassify cannabis as a Schedule III drug, a move that would be a boon to research and patient care.

On Oct. 24, legislators, health law experts and others will dicsuss the current state of telehealth policy at the Arizona Telemedicine Program’s annual summit.

Problems with edible cannabis products in Arizona spiked in 2020 during the pandemic and have stayed at a heightened number since voters legalized recreational marijuana that year.

A new study found that reactions such as chills, fatigue, headache and malaise that can follow vaccination may be signs of a vigorous immune response.

Arizona health officials this week scaled back the state's COVID-19 dashboard and declared the disease "a common respiratory illness."

Presenting at the Alzheimer’s Research and Prevention Foundation’s annual conference in Phoenix, Roberta Diaz Brinton, PhD, director of the UArizona Center for Innovation in Brain Science, cited chronic conditions that could lead to Alzheimer's disease.

Researchers with the ongoing Arizona CoVHORT research study at the Zuckerman College of Public Health were awarded $3.2 million by the National Institute of Diabetes and Digestive and Kidney Diseases for a study of gastrointestinal symptoms, specifically irritable bowel syndrome, as a condition of long COVID.

Phillip Kuo, MD, PhD, FACR, professor of medical imaging at the College of Medicine – Tucson, is interviewed about his research on the prostate cancer drug flotufolastat F 18, which was presented at the American Society for Radiation Oncology annual meeting in San Diego, California.